Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novavax Inc (NVAX) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance

Novavax IncTrade
Virgin Galactic Holdings, Inc.Trade

Price performance (Past 24H)

Key statistics

Novavax Inc vs Virgin Galactic Holdings, Inc. — how do they compare? Novavax Inc trades at $7.95 (market cap $1.30B), while Virgin Galactic Holdings, Inc. trades at $3.3 (market cap $488.94M). The key difference: Novavax Inc is far larger — about 2.7× Virgin Galactic Holdings, Inc.'s market cap, and Novavax Inc is trading nearer its 52-week high, Virgin Galactic Holdings, Inc. nearer its low. Which is the better fit depends on your goals.

NVAXSPCE
Market Cap
$1.30B$488.94M
Sector
HealthIndustrials
52-Week High
$11.19$7.52
52-Week Low
$6.22$2.17
Enterprise Value
$879.40M$588.79M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX

About Virgin Galactic Holdings, Inc.

Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.

Read more on SPCE